A Prospective Comparison Between Ureteral Stent and Nephrostomy Tube for an Urgent Drainage of Obstructed Kidney (JJVsPCN08)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified August 2008 by Rabin Medical Center.
Recruitment status was  Recruiting
Information provided by:
Rabin Medical Center
ClinicalTrials.gov Identifier:
First received: August 20, 2008
Last updated: NA
Last verified: August 2008
History: No changes posted
Kidney obstruction might be caused by a stone in the urinary tract. In case of accompanying fever or renal failure, an urgent drainage might be needed. This can be done either by placing an ureteral stent or a nephrotomy tube. Only limited number of studies examined the question which of the two is preferred. A debate exist regarding the effectiveness of each procedure to improve symptoms, renal function and treating an infection. Our goal is to resolve this debate and to state whether one way is preferred on the other.

Condition Intervention
Kidney Disease
Device: nephrostomy tube and ureteral stent

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment

Further study details as provided by Rabin Medical Center:

Primary Outcome Measures:
  • quality of life

Estimated Enrollment: 60
Study Start Date: August 2008
Estimated Primary Completion Date: August 2008 (Final data collection date for primary outcome measure)

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Inclusion Criteria: Patient suffering from obstructed kidney by a stone and at least one of these situations:

  1. fever (above 38c)
  2. A rise in creatine to above 1.5
  3. Pain resistent to multiple analgetic treatments

Exclusion Criteria:

  • Patients with medical condition that prevent the use of one of the procedures
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00739284

Contact: Shay Golan, MD 972-3-9376560 shayg@clalit.org.il

Rabin medical center Recruiting
Petach Tikva, Israel
Contact: Shay Golan, MD    972-3-9376560    shayg@clalit.org.il   
Principal Investigator: Shay Golan, MD         
Sponsors and Collaborators
Rabin Medical Center
  More Information

Responsible Party: Dr. Shay Golan, Rabin medical center, Urology department
ClinicalTrials.gov Identifier: NCT00739284     History of Changes
Other Study ID Numbers: JJVsPCN08 
Study First Received: August 20, 2008
Last Updated: August 20, 2008
Health Authority: Israel: Ethics Commission
United States: Food and Drug Administration

Keywords provided by Rabin Medical Center:

Additional relevant MeSH terms:
Kidney Diseases
Urologic Diseases

ClinicalTrials.gov processed this record on May 02, 2016